These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19298924)

  • 1. The cardiovascular programs of the National Heart, Lung, and Blood Institute: from vision to action to impact.
    Nabel EG; Lauer MS
    J Am Coll Cardiol; 2009 Mar; 53(12):1082-3. PubMed ID: 19298924
    [No Abstract]   [Full Text] [Related]  

  • 2. The Extramural Division of Cardiovascular Sciences of the National Heart, Lung, and Blood Institute.
    Lauer MS; Skarlatos SI; Bild DE
    J Am Coll Cardiol; 2009 Jul; 54(3):265-8. PubMed ID: 19589441
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
    Buxton DB
    Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015.
    Gao Y; Stanley DV; Robinson VC; Reid DM; Galis ZS
    Circ Res; 2017 May; 120(11):1713-1717. PubMed ID: 28546354
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute.
    Lundberg MS
    Circ Res; 2013 Apr; 112(8):1097-103. PubMed ID: 23580772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?
    Califf RM; Harrington RA
    J Am Coll Cardiol; 2011 Aug; 58(7):677-80. PubMed ID: 21816302
    [No Abstract]   [Full Text] [Related]  

  • 7. How to obtain a National Heart, Lung, and Blood Institute-sponsored K08 and K99/R00 grant in the current funding climate.
    Houser SR
    Circ Res; 2012 Mar; 110(7):907-9. PubMed ID: 22461360
    [No Abstract]   [Full Text] [Related]  

  • 8. The AJH visits NIH.
    Alderman MH
    Am J Hypertens; 2011 Apr; 24(4):372-3. PubMed ID: 21423127
    [No Abstract]   [Full Text] [Related]  

  • 9. K08 and K99 cardiovascular training: comparisons and trends among current awardees.
    Scott JD; Carlson DE
    Circ Res; 2012 Mar; 110(7):910-4. PubMed ID: 22461361
    [No Abstract]   [Full Text] [Related]  

  • 10. International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
    Kim ES; Carrigan TP; Menon V
    J Am Coll Cardiol; 2011 Aug; 58(7):671-6. PubMed ID: 21816301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.
    Buxton DB; Skarlatos SI
    Circ Res; 2012 Jun; 110(12):1549-55. PubMed ID: 22679137
    [No Abstract]   [Full Text] [Related]  

  • 12. What Defines a Valuable Investment in Global Health Research?
    Bloomfield GS; Narayan KM; Sampson UK; Narula J
    Glob Heart; 2016 Mar; 11(1):1-3. PubMed ID: 27102017
    [No Abstract]   [Full Text] [Related]  

  • 13. Research programs and strategies for funding. National Heart, Lung, and Blood Institute.
    Stone EJ
    Cardiovasc Nurs; 1988; 24(6):54. PubMed ID: 3203365
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspective: Late-Stage (T4) Translation Research and Implementation Science: The National Heart, Lung, and Blood Institute Strategic Vision.
    Mensah GA; Boyce CA; Price LN; Mishoe HO; Engelgau MM
    Ethn Dis; 2017; 27(4):367-370. PubMed ID: 29225436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
    Gibbons GH; Shurin SB; Mensah GA; Lauer MS
    J Am Coll Cardiol; 2013 Oct; 62(15):1396-8. PubMed ID: 24091225
    [No Abstract]   [Full Text] [Related]  

  • 16. Obesity research and programs at the National Heart, Lung, and Blood Institute.
    Simons-Morton DG; Donato K; Loria CM; Pratt CA; Ershow AG; Morrissette MA; Czajkowski S; Arteaga SS; Obarzanek E
    J Am Coll Cardiol; 2010 Mar; 55(9):917-20. PubMed ID: 20185044
    [No Abstract]   [Full Text] [Related]  

  • 17. Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective.
    Puggal MA; Schully SD; Srinivas PR; Papanicolaou GJ; Jaquish CE; Fabsitz RR
    Circ Cardiovasc Genet; 2013 Dec; 6(6):634-9. PubMed ID: 24347619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute.
    Gordon D; Cooper-Arnold K; Lauer M
    J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. $1 billion to the National Heart, Lung, and Blood Institute: economic stimulus or bust?
    Galani RJ
    J Am Coll Cardiol; 2011 Feb; 57(7):889; author reply 889. PubMed ID: 21310329
    [No Abstract]   [Full Text] [Related]  

  • 20. National Heart, Lung, and Blood Institute and the American Recovery and Reinvestment Act of 2009: 1 year later.
    Lauer MS
    J Am Coll Cardiol; 2010 Jul; 56(3):234-6. PubMed ID: 20620744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.